Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Terry,

The enrollment has been glacial at best for NEO and likely for HOT. With the things are progressing at Advaxis, the best shot to see the next batch of clinical data is either AACR or ASCO in 2020.
As for the prostate combo data, we have no idea what's going on there. The management has been mum about the future of this trial, and I'm really puzzled by the lack of any progress there. Why MRK is not jumping and partnering with ADXS if the data is good, as we were told? I'm afraid the management will just put this program into a back-burner and let it disappear from screens. That's what they have done with other programs that consumed tens of millions of dollars with nothing to show for.